Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

6
SummaryChartsNewsCalendarCompanyFinancials 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology.

It operates through the Cancer and Dermatology segments.

The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United States.

The Dermatology segment involves sale of MAL substance and the deferred recognition of Metvix revenue from Galderma.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 47 persons.
Sales per Businesses
20132014Delta
NOK (in Million)%NOK (in Million)%
Cancer78.5694%92.0171.4% +14.62%
Dermatology5.056%1.571.2% -221.37%
Sales per Regions
20132014Delta
NOK (in Million)%NOK (in Million)%
Norway83.62100%---
Partner Countries Europe--47.8937.1%-
Nordic Region--33.4225.9%-
United States--12.289.5%-
Managers
NameAgeSinceTitle
Kjetil Hestdal PhD, MD551997President, Chief Executive Officer & Press Contact
Åse Aulie Michelet631996Chairman
Kathleen Deardorff PharmD562011Chief Operating Officer & IR Contact
Erik Dahl-2012Chief Financial Officer & IR Officer
Inger Ferner Heglund602006Vice President-Research & Development
Jon Hindar592006Independent Director
Eva Steiness MD, DSc742008Independent Director
Mats Gunnar Pettersson, CPA702008Independent Director
Xavier Denis Yon742011Independent Director
Grete Hogstad592005Vice President-Strategic Marketing
Shareholders
NameShares%
Hunter Hall Investment Management Ltd. 2,957,334 13.8%
KLP Kapitalforvaltning AS 2,217,165 10.4%
Fondsfinans Kapitalforvaltning ASA 2,054,371 9.60%
Radiumhospitalets Forskningsstiftelse 2,029,000 9.48%
Danske Capital AS 888,181 4.15%
MP Pensjon PK 850,000 3.97%
Skagen AS 626,466 2.93%
DNB Asset Management AS 605,496 2.83%
Bergen Kommunale Pensjonskasse 500,000 2.34%
Eika Kapitalforvaltning AS 476,517 2.23%
Holdings
NameShares%Valuation
PCI Biotech Holding ASA (PCIB) 1,726,00411.6%2,468,030 USD
Photocure ASA (PHO) 32,4760.15%170,341 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ALLERGAN PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Photocure ASA : Connections
Phlogo ApS
Medical Instill Technologies, Inc
The Oticon Foundation
Clinique des Champs Elysees
Bio-Medisinsk Innovasjon AS
Newpharma.dk
Teres Medical Group AS
Chester Valley Pharmaceuticals, Inc.
Michelson Diagnostics Ltd.
Goapharma SAS
L. Gill-Johannessen AS
Laboratoires Panpharma SA
to-BBB Holding BV
Elastagen Pty Ltd.
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2015 People , Fundamentals and Ownership